The antidepressant effects of a single low-dose ketamine infusion typically last between 3 and 14 days before symptoms begin to return. Peak benefit occurs around 24 hours after the infusion, with a gradual decline over the following one to two weeks. Repeated infusion protocols -- usually 6 sessions over 2 to 3 weeks -- can extend the overall duration of response, and ongoing maintenance infusions help sustain long-term improvement.
Why Do Effects Fade?
Ketamine's antidepressant mechanism involves triggering a rapid cascade of neuroplastic changes, including the formation of new dendritic spines and synaptic connections in the prefrontal cortex and hippocampus. These structural changes are driven by BDNF release and mTOR-dependent protein synthesis. However, newly formed synapses require reinforcement to become permanent. Without continued stimulation from additional treatments, many of these new connections are pruned by normal homeostatic processes, and depressive symptoms can recur.
The 3-to-14-day duration of effect after a single infusion corresponds roughly to the lifespan of unstabilized new synapses in preclinical models. This biological timeline explains why repeated treatments are necessary and why maintenance protocols have become standard clinical practice.
Building and Sustaining the Response
An initial course of ketamine therapy typically involves 6 intravenous infusions delivered over 2 to 3 weeks. This repeated dosing schedule reinforces synaptic changes, and many patients report progressively longer intervals between symptom return as the series continues. After the initial course, maintenance infusions are scheduled at intervals of 2 to 6 weeks based on each patient's individual response pattern.
Some patients maintain their improvement for several weeks between maintenance sessions, while others require more frequent treatments. Clinicians often use validated depression scales such as the PHQ-9 or MADRS to track symptoms and guide the timing of maintenance infusions. Combining ketamine treatment with ongoing psychotherapy and conventional antidepressants may also help extend the duration of benefit.
For a comprehensive discussion of treatment protocols and long-term management, see the Ketamine for Depression Comprehensive Guide.
References
- PubMed: Duration of Antidepressant Effect of Single Dose IV Ketamine — Clinical study documenting the time course of ketamine's antidepressant effects
- NIH: Ketamine as a Rapid-Acting Antidepressant — NIMH research information on rapid-acting antidepressant development
- PubMed: Repeated Ketamine Infusions for Treatment-Resistant Depression — Review of repeated dosing protocols and durability of response
Share